Establishment of Quality Standard for Metaiodobenzylguanidine as Radiopharmaceutical Precursor

Establishment of Quality Standard for Metaiodobenzylguanidine as Radiopharmaceutical Precursor

Meta-iodobenzylguanidine (MIBG) is used as a chemical precursor of radioiodinated (123I or 131I) MIBG preparation. In order to control the quality of MIBG, in this study, Infrared identification of self-made MIBG was carried out, the physical and chemical properties of solubility, pH, melting point...

Full description

Bibliographic Details
Main Author:	CHEN Mengyi;DONG Ruilin;XING Yu;ZHOU Jiajun;QIU Shanshan;SUN Mingyue;WANG Xiaoming;WU Fuhai;HU Ji
Format:	Article
Language:	zho
Published:	Editorial Board of Journal of Isotopes 2023-02-01
Series:	Journal of Isotopes
Subjects:	metaiodobenzylguanidine radiopharmaceutical precursor quality standard hplc
Online Access:	http://www.tws.org.cn/CN/10.7538/tws.2022.youxian.042

Similar Items

Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography
by: A. A. Ansheles, et al.
Published: (2016-07-01)

Metaiodobenzylguanidine in the assessment of the ends of myocardial sympathetic fibers in patients with bronchial asthma
by: S A Boitsov, et al.
Published: (2003-03-01)

Cardiac I-metaiodobenzylguanidine Scintigraphy in a Patient with Familial Parkinsonism with Gene Mutation
by: Young-Do Kim, et al.
Published: (2010-10-01)

Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals
by: Erik de Blois, et al.
Published: (2019-01-01)

I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
by: Eun Joo Chung, et al.
Published: (2015-05-01)

Uptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
by: Yoshito Kamiya, et al.
Published: (2017-01-01)

Regulation of Radiopharmaceutical Products
by: V. V. Kosenko, et al.
Published: (2022-12-01)

Radiopharmaceuticals for positron emission tomography /
by: Scott, Peter J. H., et al.
Published: (c201)

Complete remission of metastatic pheochromocytoma in 123I-metaiodobenzylguanidine scintigraphy after a single session of 131I-metaiodobenzylguanidine therapy: a case report
by: Teruaki Sugino, et al.
Published: (2017-12-01)

New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals
by: I. F. Antunes, et al.
Published: (2020-05-01)

Compliance and initiative: A discussion on the relationship between standards and activities in radiopharmaceutical production
by: Gerferson André Silva Costa, et al.
Published: (2024-02-01)

Radiopharmaceuticals : progress and clinical perspectives /
by: Fritzberg, Alan R.
Published: (1986)

Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
by: Yoshito Kamiya, et al.
Published: (2018-06-01)

Radiopharmaceuticals and other compounds labelled with shortlived radionuclides /
by: Welch, Michael J.
Published: (1977)

Radiopharmaceuticals from generator-produced radionuclides
by: International Atomic Energy Agency
Published: (1971)

Dosing Therapeutic Radiopharmaceuticals in Obese Patients
by: Merel van Nuland, et al.
Published: (2022-01-01)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
by: Mai Lin, et al.
Published: (2022-10-01)

The Prognostic Value of the Results of <sup>123</sup>I-metaiodobenzylguanidine Myocardial Scintigraphy in the Examination of Patients with Atrial Fibrillation Referred for Its Interventional Treatment
by: Yu. V. Varlamova, et al.
Published: (2019-11-01)

Implementation of automated radiopharmaceutical dispenser with integrated radiation shielding
by: Somsakul Thumvijit, et al.
Published: (2009-09-01)

Radiopharmaceuticals for imaging chronic lymphocytic inflammation
by: Gaurav Malviya, et al.
Published: (2007-09-01)

Current Status and Future Prospects of Theranostics with Radiopharmaceuticals
by: LUO Yaping, et al.
Published: (2023-07-01)

EANM guideline on the validation of analytical methods for radiopharmaceuticals
by: Nic Gillings, et al.
Published: (2020-02-01)

In vitro radioautographic studies of the biodistribution of radiopharmaceuticals on blood elements
by: Ripoll-Hamer E., et al.
Published: (1998-01-01)

Radiopharmaceuticals for the Treatment of COVID-19
by: LUO Zhifu;FAN Caiyun;LI Fenglin;CHEN Baojun;LIU Zihua;XIE Qinghua
Published: (2022-02-01)

Pharmacokinetic Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2022-12-01)

Drug interaction with radiopharmaceuticals: effect on the labeling of red blood cells with technetium-99m and on the bioavailability of radiopharmaceuticals
by: Maria Luisa Gomes, et al.
Published: (2002-09-01)

Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine
by: Stefano Mastrangelo, et al.
Published: (2022-10-01)

Optimization of 177Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application
by: Aylin Cankaya, et al.
Published: (2023-05-01)

Fundamental concepts of radiopharmaceuticals quality controls
by: Sajjad Molavipordanjani, et al.
Published: (2018-12-01)

Guidance on validation and qualification of processes and operations involving radiopharmaceuticals
by: S. Todde, et al.
Published: (2017-06-01)

Nano-radiopharmaceuticals as therapeutic agents
by: Tanu Dixit, et al.
Published: (2024-03-01)

Radiopharmaceutical Validation for Clinical Use
by: Charles A. Kunos, et al.
Published: (2021-03-01)

A Specific HPLC Method to Determine Residual HEPES in [<sup>68</sup>Ga]Ga-Radiopharmaceuticals: Development and Validation
by: Silvia Migliari, et al.
Published: (2022-07-01)

Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors
by: Anh Thu Nguyen, et al.
Published: (2023-06-01)

The Recent Research Development of 177Lu Radiopharmaceuticals
by: YANG Yuchuan;KAN Wentao;YANG Xia;WEI Hongyuan;ZHUO Liangang;WANG Jing;LIAO Wei;ZHAO Peng;WANG Guanquan
Published: (2022-06-01)

Aptamer-based therapeutics and their potential in radiopharmaceutical design
by: Catia S. M. Ferreira, et al.
Published: (2007-09-01)

External radiation doses from patients administered with radiopharmaceuticals measurements and Monte Carlo simulation
by: Kinsara Abdul Raheem, et al.
Published: (2014-01-01)

Radiopharmaceuticals for Relapsed or Refractory Leukemias
by: Charles A. Kunos, et al.
Published: (2019-02-01)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
by: Liesbeth Everix, et al.
Published: (2023-02-01)

Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options
by: Burcu Altıparmak Güleç, et al.
Published: (2021-07-01)